Literature DB >> 2953789

Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.

E R Nisbet-Brown, J W Lee, R K Cheung, E W Gelfand.   

Abstract

We have directly compared the signals required for: induction of the [Ca+2]i response, expression of Tac antigen, and proliferation in antigen-specific human T cell clones. We have previously shown that antigen-specific activation of cloned T cells under conditions leading to proliferation is accompanied by a rapid increase in [Ca+2]i. Cloned T cells showed increased [Ca+2]i, enhanced Tac expression, and proliferated in response to specific antigen in the presence of viable, genetically appropriate antigen-presenting cells. Paraformaldehyde fixation of antigen-presenting cells after "pulsing" with antigen prevented proliferation, but did not affect MHC-restricted [Ca+2]i or Tac responses. Treatment of cloned T cells with monoclonal anti-T3 antibody also increased [Ca+2]i and Tac expression but did not induce proliferation. Proliferation was restored by viable autologous or allogenic APC or exogenous IL 2, but not by IL 1. In contrast to resting T cells, T cell clones were insensitive to the mitogenic effects of lectins or of ionophores and phorbol esters. These results suggest that activation of antigen-specific T cells requires the sequential action of at least two signals. The first is MHC restricted and is mediated by interaction of antigen + MHC class II products with the T cell receptor (T3-Ti) complex. This leads to Tac expression and increased [Ca+2]i, but is not sufficient for proliferation. This signal can be bypassed by anti-T3 monoclonal antibodies. Proliferation requires a second, nonantigen-specific, non-MHC-restricted antigen-presenting cell signal, which cannot be replaced by IL 1 in our system. This signal can be bypassed, however, by the addition of exogenous IL 2 to cells that have received the first signal and express Tac, suggesting that it is required for IL 2 synthesis and secretion. T cell clones therefore provide a useful model for studying antigen-dependent and -independent events in cell activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).

Authors:  C L Jellis; S S Wang; P Rennert; F Borriello; A H Sharpe; N R Green; G S Gray
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.

Authors:  T A Poulton; A Gallagher; R C Potts; J S Beck
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

3.  Alpha-interferon enhances gamma-interferon production of peripheral blood mononuclear cells pre-activated with phytohemagglutinin.

Authors:  K Katayama; N Hayashi; T Takehara; K Suzuki; A Kasahara; H Fusamoto; T Kamada
Journal:  Gastroenterol Jpn       Date:  1993-10

Review 4.  Accessory cell-derived signals required for T cell activation.

Authors:  J G Johnson; M K Jenkins
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

5.  Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers.

Authors:  K Katayama; N Hayashi; T Takehara; T Towata; A Kasahara; H Fusamoto; T Kamada
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

6.  Functional properties of intra-epithelial lymphocytes from mouse small intestine. IV. Investigation of the proliferative capacity of IEL using phorbol ester and calcium ionophore.

Authors:  A M Mowat; I B McInnes; D M Parrott
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

7.  Role of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factors.

Authors:  G Majumdar; H Ohnishi; M A Tomai; A M Geller; B Wang; M E Dockter; M Kotb
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.